These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2468608)

  • 1. Human immune response to meningococcal outer membrane protein epitopes after natural infection or vaccination.
    Mandrell RE; Zollinger WD
    Infect Immun; 1989 May; 57(5):1590-8. PubMed ID: 2468608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.
    Rosenqvist E; Harthug S; Frøholm LO; Høiby EA; Bøvre K; Zollinger WD
    J Clin Microbiol; 1988 Aug; 26(8):1543-8. PubMed ID: 3139705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities and epitope specificity of human and murine antibodies against the class 4 outer membrane protein (Rmp) of Neisseria meningitidis.
    Rosenqvist E; Musacchio A; Aase A; Høiby EA; Namork E; Kolberg J; Wedege E; Delvig A; Dalseg R; Michaelsen TE; Tommassen J
    Infect Immun; 1999 Mar; 67(3):1267-76. PubMed ID: 10024570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immune response to epitopes on the meningococcal outer membrane class 5 protein following natural infection.
    Danelli MG; Alves CM; Bastos RC; Batoreu NM; Barroso DE; Peralta JM; Frasch CE
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):159-68. PubMed ID: 8880142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.
    Wedege E; Høiby EA; Rosenqvist E; Bjune G
    Infect Immun; 1998 Jul; 66(7):3223-31. PubMed ID: 9632589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide.
    Estabrook MM; Mandrell RE; Apicella MA; Griffiss JM
    Infect Immun; 1990 Jul; 58(7):2204-13. PubMed ID: 1694820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccine.
    Delvig AA; Wedege E; Caugant DA; Dalseg R; Kolberg J; Achtman M; Rosenqvist E
    Microbiology (Reading); 1995 Jul; 141 ( Pt 7)():1593-600. PubMed ID: 7551027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease.
    Guttormsen HK; Wetzler LM; Naess A
    Infect Immun; 1993 Nov; 61(11):4734-42. PubMed ID: 8406872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine.
    Milagres LG; Gorla MC; Sacchi CT; Rodrigues MM
    Infect Immun; 1998 Oct; 66(10):4755-61. PubMed ID: 9746575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to meningococcal class 1 outer membrane proteins in South African complement-deficient and complement-sufficient subjects.
    Orren A; Warren RE; Potter PC; Jones AM; Lachmann PJ; Poolman JT
    Infect Immun; 1992 Nov; 60(11):4510-6. PubMed ID: 1398965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional activity of anti-Neisserial surface protein A monoclonal antibodies against strains of Neisseria meningitidis serogroup B.
    Moe GR; Zuno-Mitchell P; Lee SS; Lucas AH; Granoff DM
    Infect Immun; 2001 Jun; 69(6):3762-71. PubMed ID: 11349041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
    van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
    Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human bactericidal antibody response to meningococcal outer membrane protein vaccines.
    Zollinger WD; Boslego J; Frøholm LO; Ray JS; Moran EE; Brandt BL
    Antonie Van Leeuwenhoek; 1987; 53(6):403-11. PubMed ID: 3130779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease.
    Guttormsen HK; Wetzler LM; Solberg CO
    Infect Immun; 1994 Apr; 62(4):1437-43. PubMed ID: 8132350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.
    Moran EE; Brandt BL; Zollinger WD
    Infect Immun; 1994 Dec; 62(12):5290-5. PubMed ID: 7960107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
    Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new variant of serosubtype P1.16 in Neisseria meningitidis from Norway, associated with increased resistance to bactericidal antibodies induced by a serogroup B outer membrane protein vaccine.
    Rosenqvist E; Høiby EA; Wedege E; Caugant DA; Frøholm LO; McGuinness BT; Brooks J; Lambden PR; Heckels JE
    Microb Pathog; 1993 Sep; 15(3):197-205. PubMed ID: 7505873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody recognition of members of the meningococcal P1.10 variable region family: implications for serological typing and vaccine design.
    Suker J; Feavers IM; Maiden MCJ
    Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():63-69. PubMed ID: 8581171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.
    Schmiel DH; Moran EE; Keiser PB; Brandt BL; Zollinger WD
    Infect Immun; 2011 Oct; 79(10):4146-56. PubMed ID: 21768280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.